pamidronate has been researched along with Diabetes Mellitus, Adult-Onset in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lazarovici, TS | 1 |
Yahalom, R | 1 |
Taicher, S | 1 |
Elad, S | 1 |
Hardan, I | 1 |
Yarom, N | 1 |
Hay, KD | 1 |
Bishop, PA | 1 |
Naqvi, A | 1 |
Cuchacovich, R | 1 |
Saketkoo, L | 1 |
Espinoza, LR | 1 |
Jude, EB | 1 |
Selby, PL | 1 |
Burgess, J | 1 |
Lilleystone, P | 1 |
Mawer, EB | 1 |
Page, SR | 1 |
Donohoe, M | 1 |
Foster, AV | 1 |
Edmonds, ME | 1 |
Boulton, AJ | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Efficacy of Treatment With DENOsumab of an Acute CHARCOT Foot in Patients With Diabetes. A Multicenter, Double-blind, Randomized, Placebo-controlled Trial.[NCT04547348] | Phase 3 | 38 participants (Anticipated) | Interventional | 2020-11-01 | Recruiting | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 trial available for pamidronate and Diabetes Mellitus, Adult-Onset
Article | Year |
---|---|
Bisphosphonates in the treatment of Charcot neuroarthropathy: a double-blind randomised controlled trial.
Topics: Adult; Aged; Alkaline Phosphatase; Anti-Inflammatory Agents; Arthropathy, Neurogenic; Biomarkers; Bo | 2001 |
3 other studies available for pamidronate and Diabetes Mellitus, Adult-Onset
Article | Year |
---|---|
Bisphosphonate-related osteonecrosis of the jaws: a single-center study of 101 patients.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Alendronate; Angiogenesis Inhibitors; Anti-Bac | 2009 |
Association of osteonecrosis of the jaws and bisphosphonate pharmacotherapy: dental implications.
Topics: Adenocarcinoma; Aged, 80 and over; Bone Density Conservation Agents; Carcinoma; Diabetes Mellitus, T | 2006 |
Acute Charcot arthropathy successfully treated with pamidronate: long-term follow-up.
Topics: Aged, 80 and over; Arthropathy, Neurogenic; Bone Density Conservation Agents; Diabetes Mellitus, Typ | 2008 |